MC
LH icon

Martin & Co’s Labcorp LH Stock Holding History

Martin & Co’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.92M Buy
21,153
+221
+1% +$58.1K 0.93% 26
2026
Q1 		$5.58M Buy
20,932
+224
+1% +$60.7K 0.95% 24
2025
Q4 		$5.2M Buy
20,708
+657
+3% +$174K 0.89% 27
2025
Q3 		$5.76M Sell
20,051
-52
-0.3% -$13.9K 1.02% 20
2025
Q2 		$5.28M Buy
20,103
+156
+0.8% +$38K 0.97% 23
2025
Q1 		$4.64M Buy
19,947
+100
+0.5% +$24.3K 0.9% 26
2024
Q4 		$4.55M Sell
19,847
-838
-4% -$192K 1.13% 27
2024
Q3 		$4.62M Buy
20,685
+8
+0% +$1.76K 1.09% 30
2024
Q2 		$4.21M Sell
20,677
-146
-0.7% -$29.7K 1.06% 31
2024
Q1 		$4.55M Sell
20,823
-571
-3% -$126K 1.11% 29
2023
Q4 		$4.86M Sell
21,394
-330
-2% -$69.3K 1.2% 24
2023
Q3 		$4.37M Sell
21,724
-3,832
-15% -$808K 1.15% 25
2023
Q2 		$5.3M Sell
25,556
-1,041
-4% -$202K 1.34% 22
2023
Q1 		$5.24M Sell
26,597
-677
-2% -$139K 1.35% 20
2022
Q4 		$5.52M Buy
27,274
+729
+3% +$142K 1.46% 17
2022
Q3 		$4.67M Buy
26,545
+776
+3% +$159K 1.39% 19
2022
Q2 		$5.19M Buy
25,769
+1,028
+4% +$219K 1.48% 18
2022
Q1 		$5.6M Sell
24,741
-1,789
-7% -$421K 1.43% 20
2021
Q4 		$7.16M Sell
26,530
-6,346
-19% -$1.57M 1.64% 16
2021
Q3 		$7.95M Buy
32,876
+2,626
+9% +$662K 1.87% 12
2021
Q2 		$7.17M Sell
30,250
-1,467
-5% -$334K 1.78% 13
2021
Q1 		$6.95M Sell
31,717
-852
-3% -$171K 1.75% 13
2020
Q4 		$5.7M Buy
32,569
+117
+0.4% +$20.2K 1.46% 18
2020
Q3 		$5.25M Sell
32,452
-181
-0.6% -$28.7K 1.54% 14
2020
Q2 		$4.66M Sell
32,633
-6,580
-17% -$910K 1.44% 16
2020
Q1 		$4.26M Buy
+39,213
New +$5.65M 1.52% 15

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Martin & Co's LH Position: Q2 2026 in Review

Martin & Co increased its Labcorp (LH) stake by 1.1% in Q2 2026, buying an estimated $58.1K and bringing the position to 21,153 shares worth $5.92M. The position accounts for 0.93% of the portfolio, ranked #26.

Martin & Co first reported a position in LH in Q1 2020 and has held it in 26 quarters since. The position peaked at $7.95M in Q3 2021. 1,055 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Martin & Co held 21,153 shares of Labcorp worth $5.92M as of Q2 2026.
  • Martin & Co bought 221 Labcorp shares in Q2 2026, an estimated $58.1K.
  • Labcorp made up 0.93% of Martin & Co's portfolio in Q2 2026, its #26 holding.
  • Martin & Co first reported a position in Labcorp in Q1 2020 and has held it in 26 quarters since.
  • Martin & Co's Labcorp position peaked at $7.95M in Q3 2021.
  • 1,055 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.